Psilocybin and the Potential for “Psychedelic Therapies”

Dr. Frederick Barrett discusses recent and upcoming studies into psilocybin -- the psychoactive ingredient that puts the "magic" in magic mushrooms.  This currently "Schedule 1" drug, in addition to reasonably reliably provoking mystical experiences in users, also shows promise as a therapeutic treatment for depression, PTSD, and hospice care.  Dr. Barrett and colleagues at Johns Hopkins Medical Center are at the forefront of the latest research.
The post Psilocybin and the Potential for “Psychedelic Therapies” appeared first on Smart Drug Smarts.